Jinming Cao
Overview
Explore the profile of Jinming Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao J, Chen Z, Wang Y, Ma Y, Yang Z, Cai J, et al.
Front Pharmacol
. 2025 Jan;
15:1517546.
PMID: 39867657
Background: In the past few decades, selective serotonin reuptake inhibitors (SSRIs) became widely used antidepressants worldwide. Therefore, the adverse reactions of patients after SSRI administration became a public and clinical...
2.
Chen Z, Cao J, Xiao Z, Yang Z, Cheng Y, Duan J, et al.
Front Pharmacol
. 2024 Dec;
15:1485885.
PMID: 39720595
Objective: This study aimed to investigate the underlying mechanism of chronic stress promoting ovarian cancer growth comorbid with depression and evaluate the potential role of histamine (HIS) in treating this...
3.
Cao J, Chen Z, Xu F
Eur J Hosp Pharm
. 2024 Dec;
32(2):195-196.
PMID: 39694632
No abstract available.
4.
Xue M, You Y, Zhang L, Cao J, Xu M, Chen S
BMC Plant Biol
. 2024 Nov;
24(1):1048.
PMID: 39506700
Heat stress has become one of the abiotic stresses that pose an increasing threat to maize production due to global warming. The Hsp20 gene family confers tolerance to various abiotic...
5.
Cao J, Wu M, Mo W, Zhao M, Gu L, Wang X, et al.
Mol Med
. 2024 Oct;
30(1):182.
PMID: 39434056
Background: Radiation-induced skin injury (RISI) represents a significant complication in patients receiving radiotherapy and individuals exposed to nuclear accidents, characterized by a protracted wound-healing process relative to injuries from other...
6.
Su Z, Chen Z, Cao J, Li C, Duan J, Zhou T, et al.
Clin Psychopharmacol Neurosci
. 2024 Oct;
22(4):594-609.
PMID: 39420607
Objective: Whether peripheral blood 5-hydroxytrptamine (5-HT) levels serve as biomarker for depression diagnosis/response evaluation has not been well determined. This work was explored to address this inconclusive issue. Methods: Animals...
7.
Ge S, Jia T, Shi J, Cao J, Sang S, Li J, et al.
Bioorg Chem
. 2024 Aug;
152:107745.
PMID: 39213795
The diagnosis and treatment of triple negative breast cancer (TNBC) are huge challenges due to the lack of identifiable molecular targets. The high expression of Nectin4 in a variety of...
8.
YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
Li Y, Wang X, Yu H, Cao J, Xie J, Zhou J, et al.
Mol Carcinog
. 2024 Jul;
63(10):1953-1966.
PMID: 39016677
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive tumors with poor prognosis and inadequate response to treatment, such as gemcitabine (Gem), the first-line chemotherapeutic drug. Understanding the molecular...
9.
Xiao Z, Cao J, Wu S, Zhou T, Li C, Duan J, et al.
CNS Neurosci Ther
. 2024 Jul;
30(7):e14862.
PMID: 39009505
Background: The emergence of cyclin-dependent kinases 4/6 inhibitors (CDK4/6i) represented a major breakthrough in the treatment of breast cancer over the past decade. In both clinical trials and real-world settings,...
10.
Zhang Y, Han J, Li J, Cao J, Zhou Y, Deng S, et al.
J Cancer Res Clin Oncol
. 2024 May;
150(5):265.
PMID: 38769201
Background: Incidental colorectal fluorodeoxyglucose (FDG) uptake, observed during positron emission tomography/computed tomography (PET/CT) scans, attracts particular attention due to its potential to represent both benign and pre-malignant/malignant lesions. Early detection...